Analysts optimistic on Esperion Therapeutics Inc outlook

The Esperion Therapeutics Inc (NMQ:ESPR) share price has risen by 32.0% over the past month and it’s currently trading at 44.31. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Esperion Therapeutics Inc currently has:

• 6 Buy recommendations
• 3 Hold recommendations
• 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

At its current price of 44.31, shares in Esperion Therapeutics Inc are trading at a discount of -41.0% to its 52 week high price. The 1-year performance of the shares has been -10.8%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Esperion Therapeutics Inc it's worth doing some investigation yourself.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Esperion Therapeutics it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Esperion Therapeutics that you can find out about here.